Publications by authors named "Stephen B Fritz"
Article Synopsis
- The ARC004 study explored the long-term effects and various dosing regimens of daily oral immunotherapy with Peanut allergen powder (PTAH) in peanut-allergic children and adolescents, following positive results from the PALISADE trial.
- A total of 358 participants, both those who had continued from the PALISADE trial and new participants, underwent different daily or non-daily dosing strategies, with safety and efficacy being assessed.
- Results indicated that daily dosing led to higher desensitization rates with sustained safety, and the immune response continued to show signs of improvement in participants over the course of the study.
Article Synopsis
- Berotralstat (BCX7353) is an oral medication under investigation for preventing hereditary angioedema (HAE) attacks, aimed at assessing its efficacy and safety over a 24-week study (APeX-2 trial).
- The trial involved 121 patients who were randomly assigned to receive either a daily dose of 110 mg or 150 mg of berotralstat, or a placebo, with the primary goal of measuring the frequency of HAE attacks.
- Results indicated that both doses of berotralstat significantly reduced attack rates compared to placebo, with minimal side effects, and the higher 150 mg dosage showed the best safety profile.
Background: Peanut allergy, for which there are no approved treatment options, affects patients who are at risk for unpredictable and occasionally life-threatening allergic reactions.
Methods: In a phase 3 trial, we screened participants 4 to 55 years of age with peanut allergy for allergic dose-limiting symptoms at a challenge dose of 100 mg or less of peanut protein (approximately one third of a peanut kernel) in a double-blind, placebo-controlled food challenge. Participants with an allergic response were randomly assigned, in a 3:1 ratio, to receive AR101 (a peanut-derived investigational biologic oral immunotherapy drug) or placebo in an escalating-dose program.
Background: Nasal polyps are a common problem that is difficult to diagnose and treat, in part because the cause of nasal polyposis is unknown. Although information on the pathogenesis of polyposis is lacking, there are reports suggesting that a genetic predisposition underlies this disorder.
Objective: We sought to better understand the basis of nasal polyposis associated with allergic rhinitis.
Background: Immunoglobulin (Ig)E-mediated hypersensitivity is a mechanism suggested to explain adverse reactions to buckwheat. This is the first reported case in the United States of a person who developed asthma and worsening allergic rhinitis after exposure to a buckwheat pillow.
Objective: To describe a patient who developed asthma and worsening allergic rhinitis after exposure to a buckwheat pillow and to provide evidence that the adverse reaction was IgE-mediated.
Bioterrorism: relevance to allergy and immunology in clinical practice.
J Allergy Clin Immunol
February 2002
It has become clear in recent months that the threat of bioterrorism is very real. All physicians need to be aware of the presenting signs and symptoms of the most likely agents. Allergists and immunologists care for a unique population of patients with several alterations of their immune system that might change the expected course of illnesses from biologic terror agents.
View Article and Find Full Text PDF